JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'bax inhibitor peptide negative control'

Search results for: 'bax inhibitor peptide negative control'

A4095 Pracinostat (SB939)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Pan-HDAC inhibitor

insoluble in H2O; ≥11.4 mg/mL
A4096 Belinostat (PXD101)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Hydroxamate-type HDAC inhibitor

insoluble in H2O; ≥15.92 mg/mL
A8173 Romidepsin (FK228, depsipeptide)

7 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC1/HDAC2 inhibitor, potent and selective

≥27.04 mg/mL
A3210 AZ20

1 Citation

Target: ATM/ATR

Summary: ATR inhibitor,potent and selective

≥20.65 mg/mL
B4794 Santacruzamate A (CAY10683)

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor, potent and selective
A4090 JNJ-26481585

3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Potent HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
A4089 Mocetinostat (MGCD0103, MG0103)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,isotype-selective and potent

insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
A4104 AR-42 (OSU-HDAC42)

2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,novel and potent

insoluble in EtOH; insoluble in H2O; ≥15.62 mg/mL
A2171 Carboplatin

Summary: Antitumor agent that forms platinum-DNA adducts.

insoluble in ETOH; ≥9.28 mg/mL
A8336 KU-60019

2 Citation

Target: ATM/ATR

Summary: ATM kinase inhibitor,potent and selective

≥27.4 mg/mL